Massive CD8 T cell response to primary HIV infection in the setting of severe clinical presentation

AIDS Research and Human Retroviruses

Volumn 28, Issue 8, 2012, Pages 789-792

  Arnoczy, Gretchen S ^a   Ferrari, Guido ^b   Goonetilleke, Nilu ^c   Corrah, Tumena ^c   Li, Hui ^d   Kuruc, Joann ^a   Schmitz, John L ^a   McGee, Kara ^b   Hicks, Charles ^b   Eron, Joseph J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; EPITOPE; EPSTEIN BARR VIRUS ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ADULT; AFRICAN AMERICAN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL EXPANSION; CERVICAL LYMPHADENOPATHY; CHILL; CHLAMYDIAL URETHRITIS; CLONAL VARIATION; CYTOMEGALOVIRUS; DECREASED APPETITE; DYSPHAGIA; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEVER; GENE REARRANGEMENT; HEMATOLOGIC MALIGNANCY; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; MALE; NAUSEA AND VOMITING; NIGHT SWEAT; ODYNOPHAGIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEXUALITY; SORE THROAT; T LYMPHOCYTE RECEPTOR GENE; THRUSH; VIRUS LOAD;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS; MALE;

EID: 84864186574     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0145     Document Type: Article

References (16)

1. Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, McNeil A, et al.: Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003; 77:11708-11717.
2. Cao J, McNevin J, Malhotra U, and McElrath MJ: Evolution of CD8 + T cell immunity and viral escape following acute HIV-1 infection. J Immunol 2003;171:3837-3846.
3. Wilson JD, Ogg GS, Allen RL, Davis C, Shaunak S, Downie J, et al.: Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection. AIDS 2000;14:225-233.
4. Streeck H, Jolin JS, Qi Y, Yassine-Diab B, Johnson RC, Kwon DS, et al.: Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4 + T cells. J Virol 2009;83:7641-7648.
5. Pantaleo G, Demarest JF, Soudeyns H, Graziosi C, Denis F, Adelsberger JW, et al.: Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV. Nature 1994;370:463-467.
6. Tindall B, Barker S, Donovan B, Barnes T, Roberts J, Kronenberg C, et al.: Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med 1988;148:945-949.
7. Davey MP, Bongiovanni KF, Kaulfersch W, Quertermous T, Seidman JG, Hershfield MS, et al.: Immunoglobulin and Tcell receptor gene rearrangement and expression in human lymphoid leukemia cells at different stages of maturation. Proc Natl Acad Sci USA 1986;83:8759-8763.
8. Goonetilleke N, Liu MK, Salazar-Gonzalez JF, Ferrari G, Giorgi E, Ganusov VV, et al.: The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 2009;206:1253-1272.
9. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, et al.: Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci USA 2008;105:7552-7557.
10. Pilcher CD, Fiscus SA, Nguyen TQ, Foust E, Wolf L, Williams D, et al.: Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005;352:1873-1883.
11. Tan LC, Gudgeon N, Annels NE, Hansasuta P, O'Callaghan CA, Rowland-Jones S, et al.: A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J Immunol 1999;162:1827-1835.
12. Papagno L, Appay V, Sutton J, Rostron T, Gillespie GM, Ogg GS, et al.: Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors. Clin Exp Immunol 2002;130:509-517.
13. Ferrari G, Korber B, Goonetilleke N, Liu MKP, Turnbull EL, et al.: Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 Infection. PLoS Pathog 2011:7:2.
14. Callan MF, Tan L, Annels N, Ogg GS, Wilson JD, O'Callaghan CA, et al.: Direct visualization of antigen-specific CD8 + T cells during the primary immune response to Epstein- Barr virus in vivo. J Exp Med 1998;187:1395-1402.
15. Akondy RS, Monson ND, Miller JD, Edupuganti S, Teuwen D, Wu H, et al.: The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8 + T cell response. J Immunol 2009;183:7919-7930.
16. Kaech SM, Wherry EJ, and Ahmed R: Effector and memory T-cell differentiation: Implications for vaccine development. Nat Rev Immunol 2002;2:251-262.